ASAN FOUNDATION
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 1989-06-23
- Employees
- 501
- Market Cap
- -
- Website
- https://ails.amc.seoul.kr
Bioequivalence Study of Anastrozole 1 mg Tablet
- Conditions
- Healthy
- First Posted Date
- 2010-04-16
- Last Posted Date
- 2010-04-16
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 24
- Registration Number
- NCT01105299
Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Aplastic Anemia
- Conditions
- Aplastic Anemia
- Interventions
- Biological: anti-thymocyte globulinBiological: filgrastimProcedure: CD3±CD19 depleted hematopoietic stem cell transplantation
- First Posted Date
- 2010-04-16
- Last Posted Date
- 2013-01-03
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 12
- Registration Number
- NCT01105273
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Strategy for Adequate Blood Pressure Lowering in the Patients With Intracranial Atherosclerosis
- Conditions
- Brain Ischemia
- Interventions
- Procedure: Aggressive BP loweringProcedure: modest blood pressure lowering
- First Posted Date
- 2010-04-15
- Last Posted Date
- 2017-03-07
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 132
- Registration Number
- NCT01104311
- Locations
- 🇰🇷
Chungnam National University Hospital, Daejeon, Chungnam, Korea, Republic of
🇰🇷Yeungnam University Hospital, Daegu, Korea, Republic of
🇰🇷Eulji University Hospital, Daejon, Korea, Republic of
Efficacy and Safety of Sevofran in Patients Scheduled for Elective Surgery Under General Anesthesia
- Conditions
- General AnesthesiaSevofluraneGeneric Drugs
- Interventions
- First Posted Date
- 2010-03-31
- Last Posted Date
- 2010-03-31
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 178
- Registration Number
- NCT01096212
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
🇰🇷Sanggye-Paik Hospital, Seoul, Korea, Republic of
Isoniazid (INH) Treatment Based on ELISPOT Assay
- First Posted Date
- 2010-03-16
- Last Posted Date
- 2013-12-12
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 831
- Registration Number
- NCT01087190
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Detection and Characterization of Lower Respiratory Infections in Critically Ill Patients
- Conditions
- Severe Pneumonia
- First Posted Date
- 2010-02-17
- Last Posted Date
- 2024-04-18
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 300
- Registration Number
- NCT01068990
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Autologous Hematopoietic Cell Transplantation for Core-binding Factor Acute Myeloid Leukemia
- Conditions
- Leukemia, Myeloid
- Interventions
- Procedure: autologous hematopoietic cell transplantation
- First Posted Date
- 2010-01-15
- Last Posted Date
- 2025-03-17
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT01050036
- Locations
- 🇰🇷
Wonkwang University Hospital, Iksan, Chollabuk-do, Korea, Republic of
🇰🇷Gyeongsang National University Hospital, Jinju, Gyeongsangnam-do, Korea, Republic of
🇰🇷Hallym University Sacred Heart Hospital, Anyang, Kyeongki-do, Korea, Republic of
RAD001 in Combination With Capecitabine and Oxaliplatin (XELOX) in Patients With Advanced Gastric Cancer: RAD001+XELOX
- Conditions
- Advanced Gastric Cancer
- Interventions
- Drug: RAD001, Capecitabine, Oxaliplatin
- First Posted Date
- 2010-01-14
- Last Posted Date
- 2020-01-07
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT01049620
- Locations
- 🇰🇷
Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of
Venous Thromboembolism in Advanced Gastric Cancer Patients
- Conditions
- Advanced Gastric Cancer
- First Posted Date
- 2010-01-13
- Last Posted Date
- 2020-01-07
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 259
- Registration Number
- NCT01047618
- Locations
- 🇰🇷
Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of
Study of Vorinostat Plus Capecitabine (X) and Cisplatin (P) for 1st Line Treatment of Metastatic or Recurrent Gastric Cancer: Zolinza+XP
- Conditions
- Gastric CancerHistone Deacetylase Inhibitor
- Interventions
- First Posted Date
- 2010-01-11
- Last Posted Date
- 2020-01-07
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 45
- Registration Number
- NCT01045538
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of